Drax Exametazime

Active Ingredient(s): Exametazime + Sodium Chloride + Stannous Chloride Dihydrate
FDA Approved: * August 17, 2017
Pharm Company: * JUBILANT DRAXIMAGE
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Drax Exametazime Overview

Technetium (99mTc) exametazime is a radiopharmaceutical sold under the trade name Ceretec, and is used by nuclear medicine physicians for the detection of altered regional cerebral perfusion in stroke[1] and other cerebrovascular diseases. It can also be used for the labelling of leukocytes to localise intra-abdominal infections[2] and inflammatory bowel disease.[3] Exametazime (the part without technetium) is sometimes referred to by its chemic...

Read more Drax Exametazime Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Technetium_(99mTc)_exametazime

Recent Drax Exametazime Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Exametazime + Sodium Chloride + Stannous Chloride Dihydrate
  • Kit: 0.5mg/vial [0.37 Gbq Up To 2.00 Gbq (10mci Up To 54mci)
  • Powder: N/a
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Drax Exametazime: (1 result)

Sorted by National Drug Code
  • 65174-200 Drax Exametazime .5 mg Intravenous Injection, Powder, Lyophilized, for Solution by Jubilant Draximage Inc.

Drugs with one or more similar ingredients: (22 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 July 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA